Sc(OTf)3/Bis(oxazoline)复合物催化的2-芳基-1,3-茚二酮与2-乙烯基吲哚的不对称Diels-Alder反应：高效构建四氢咔唑螺茚酮衍生物

doi:10.6023/A14040237

化学学报 ›› 2014, Vol. 72 ›› Issue (7): 836-840.DOI: 10.6023/A14040237 上一篇下一篇

所属专题：不对称催化与合成

研究通讯

Sc(OTf)₃/Bis(oxazoline)复合物催化的2-芳基-1,3-茚二酮与2-乙烯基吲哚的不对称Diels-Alder反应：高效构建四氢咔唑螺茚酮衍生物

谭芬^a, 陈加荣^a, 王萍^b, 肖文精^a

a 华中师范大学农药与化学生物学教育部重点实验室和化学学院武汉 430079;
b 湖北中医药大学药学院武汉 430065

投稿日期:2014-04-01 发布日期:2014-05-07
通讯作者: 王萍, 肖文精 E-mail:wxiao@mail.ccnu.edu.cn
基金资助:
项目受国家自然科学基金（Nos.21072069，21002036，21232003和21202053）与973计划（2011CB808600）资助.

Asymmetric Diels-Alder Reaction of 2-Arylidene-1,3-indanediones with 2-Vinylindoles Catalyzed by a Sc(OTf)₃/Bis(oxazoline) Complex：Enantioselective Synthesis of Tetrahydrocarbazole Spiro Indanedione Derivatives

Tan Fen^a, Chen Jiarong^a, Wang Ping^b, Xiao Wenjing^a

a Key Laboratory of Pesticide & Chemical Biology Ministry of Education and College of Chemistry, Central China Normal University, Wuhan, 430079;
b College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065

Received:2014-04-01 Published:2014-05-07
Supported by:
Project supported by the National Natural Science Foundation of China (Nos. 21072069, 21002036, 21232003, and 21202053) and the National Basic Research Program of China (973 program, 2011CB808600).

文章分享

1. Sc(OTf)₃/Bis(oxazoline)复合物催化的2-芳基-1,3-茚二酮与2-乙烯基吲哚的不对称Diels-Alder反应：高效构建四氢咔唑螺茚酮衍生物.PDF(3141KB)

摘要/Abstract

报道了Sc（OTf）₃/Bis（oxazoline）复合物催化的2-芳基-1，3-茚二酮与2-乙烯基吲哚的不对称Diels-Alder反应，简便、高效的构建了一系列手性四氢咔唑螺茚酮衍生物. 通过考察不同的金属盐和手性配体、溶剂、温度等因素对反应的影响，获得了优良的收率（up to 92% yield）和优异的对映选择性（up to 94% ee）. 该反应条件温和，具有宽广的底物适用范围和较好的官能团兼容性.

关键词: Diels-Alder反应, 不对称合成, Lewis酸催化, 1,3-茚二酮, 四氢咔唑

Spirocyclic scaffolds are prevalent in numerous naturally occurring products and pharmaceuticals, which exhibit important biological and pharmacological activities. In this communication, a Sc(OTf)₃/Bis(oxazoline) complex catalyzed asymmetric Diels-Alder reaction of 2-arylidene-1,3-indanediones with 2-vinylindoles has been developed. The reaction provides a convenient and practical approach to biologically useful and synthetically important spiro-tetrahydrocarbazoles in good yields with high enantioselectivities (16 examples, up to 92% yield, 94% ee). A representative procedure for this asymmetric Diels-Alder reaction is described below: Sc(OTf)₃ (0.02 mmol) and chiral tridentate diphenyl-pybox ligand IV (0.02 mmol) were dissolved in toluene (1.5 mL) and stirred for 30 minutes at room temperature. 2-Arylidene-1,3-indanediones (0.20 mmol) was added to the above-mentioned solution and stirred at 5 ℃ for another 30 minutes. The solution of 2-vinylindoles (0.20 mmol) in toluene (0.5 mL) was then added to the reaction system and the mixture was stirred until the complete consumption of substrates (as monitored by TLC). The reaction mixture was purified directly by flash column chromatography on silica gel (petroleum ether/ethyl acetate=15:1～10:1) to give the corresponding products.

Key words: Diels-Alder reaction, asymmetric synthesis, Lewis acid catalysis, 1,3-indanedione, tetrahydrocarbazole

引用此文

谭芬, 陈加荣, 王萍, 肖文精. Sc(OTf)₃/Bis(oxazoline)复合物催化的2-芳基-1,3-茚二酮与2-乙烯基吲哚的不对称Diels-Alder反应：高效构建四氢咔唑螺茚酮衍生物[J]. 化学学报, 2014, 72(7): 836-840.

Tan Fen, Chen Jiarong, Wang Ping, Xiao Wenjing. Asymmetric Diels-Alder Reaction of 2-Arylidene-1,3-indanediones with 2-Vinylindoles Catalyzed by a Sc(OTf)₃/Bis(oxazoline) Complex：Enantioselective Synthesis of Tetrahydrocarbazole Spiro Indanedione Derivatives[J]. Acta Chimica Sinica, 2014, 72(7): 836-840.

导出引用 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

分享此文

参考文献

[1] For recent reviews, see: (a) Clive, D. L. J.; Yu, M.; Wang, J.; Yeh, V. S. C.; Kang, S. Chem. Rev. 2005, 105, 4483.
(b) Galliford, C. V.; Scheidt, K. A. Angew. Chem. Int. Ed. 2007, 46, 8748.
(c) Millemaggi, A.; Taylor, R. J. K. Eur. J. Org. Chem. 2010, 4527.
(d) Yu, J.; Shi, F.; Gong, L.-Z. Acc. Chem. Res. 2011, 44, 1156.
(e) Rios, R. Chem. Soc. Rev. 2012, 41, 1060.
(f) Franz, A. K.; Hanhan, N. V.; Ball-Jones, N. R. ACS Catal. 2013, 3, 540.
[2] For selected recent examples, see: (a) Yip, K.-T.; Zhu, N.-Y.; Yang, D. Org. Lett. 2009, 11, 1911.
(b) Girgis, A. S. Eur. J. Med. Chem. 2009, 44, 91.
(c) Sirasani, G.; Andrade, R. B. Org. Lett. 2009, 11, 2085.
(d) Cheng, L.; Liu, L.; Jia, H.; Wang, D.; Chen, Y.-J. J. Org. Chem. 2009, 74, 4650.
(e) Li, B.; Zhou, R.; He, G.; Guo, L.; Huang, W. Acta Chim. Sinica 2013, 71, 1396. (李博, 周锐, 何谷, 郭丽, 黄维, 化学学报, 2013, 71, 1396.) For chapters and selected reviews, see:
(f) Indoles, Ed.: Sundberg, R. J., Academic Press, San Diego, CA, 1996.
(g) Kleeman, A.; Engel, J.; Kutscher, B.; Reichert, D. Pharmaceutical Substances, 4th ed., Thieme, New York, 2001.
(h) Dewick, P. M. Medicinal Natural Products: A Biosynthetic Approach, 2nd ed., Wiley, New York, 2002.
(i) Fattorusso, E.; Scafati, O. T. Modern Alkaloids, WILEY-VCH, Weinheim, 2008.
(j) Knölker, H. J.; Reddy, K. R. Chem. Rev. 2002, 102, 4303.
(k) Cacchi, S.; Fabrizi, G. Chem. Rev. 2005, 105, 2873.
[3] (a) Wang, Y.; Ding, K. Chin. J. Org. Chem. 2001, 21, 763. (王以, 丁奎岭, 有机化学, 2001, 21, 763. )
(b) Zeni, G.; Larock, R. C. Chem. Rev. 2004, 104, 2285.
(c) Sheng, Y.-F.; Zhang, A.-J.; Zheng, X.-J.; You, S.-L. Chin. J. Org. Chem. 2008, 28, 605. (盛益飞, 张安将, 郑晓建, 游书力, 有机化学, 2008, 28, 605.)
(d) Bandini, M.; Eichholzer, A. Angew. Chem. Int. Ed. 2009, 48, 9608.
[4] Selected recent examples for the asymmetric synthesis of tetrahydrocarbazoles, see: (a) Gioia, C.; Hauville, A.; Bernardi, L.; Fini, F.; Ricci, A. Angew. Chem. Int. Ed. 2008, 47, 9236.
(b) Jones, S. B.; Simmons, B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2009, 131, 13606.
(c) Bandini, M.; Eichholzer, A.; Gualandi, A.; Quinto, T.; Savoia, D. ChemCatChem 2010, 2, 661.
(d) Tan, B.; Hernández-Torres, G.; Barbas Ⅲ, C. F. J. Am. Chem. Soc. 2011, 133, 12354.
(e) Müller, S.; Webber, M. J.; List, B. J. Am. Chem. Soc. 2011, 133, 18534.
(f) Liu, Y.; Nappi, M.; Arceo, E.; Vera, S.; Melchiorre, P. J. Am. Chem. Soc. 2011, 133, 15212.
(g) Cai, Q.; Zheng, C.; Zhang, J.-W.; You, S.-L. Angew. Chem. Int. Ed. 2011, 50, 8665.
(h) Cai, Q.; You, S.-L. Org. Lett. 2012, 14, 3040.
(i) Wu, Q.-F.; Zheng, C.; You, S.-L. Angew. Chem. Int. Ed. 2012, 51, 1680.
(j) Liu, Y.; Nappi, M.; Escudero-Adán, E. C.; Melchiorre, P. Org. Lett. 2012, 14, 1310.
(k) Xiao, Y.-C.; Zhou, Q.-Q.; Dong, L.; Liu, T.-Y.; Chen, Y.-C. Org. Lett. 2012, 14, 5940.
(l) Bandini, M.; Bottoni, A.; Chiarucci, M.; Cera, G.; Miscione, G. P. J. Am. Chem. Soc. 2012, 134, 20690.
[5] Murdock, K. C. J. Org. Chem. 1959, 24, 845.
[6] (a) Khordorkovsky, V.; Mazor, R. A.; Ellern, A. Acta Crystallogr. 1996, C52, 2878.
(b) Schwartz, H.; Mazor, R.; Khordorkovsky, V.; Shapiro, L.; Klug, J. T.; Kovalev, E.; Meshulum, G.; Berkovic, G.; Kotler, Z.; Efrima, S. J. Phys. Chem. 2001, 105, 5914.
[7] Nishiyama, T.; Shiotsu, S.; Tsujita, H. Polym. Degrad. Stab. 2002, 76, 435.
[8] (a) Nugiel, D.; Etzkorn, A.; Vidwans, A.; Benfield, P.; Bosclair, M.; Burton, C.; Cox, S.; Czerniak, M.; Doleniak, D.; Seitz, S. J. Med. Chem. 2001, 44, 1334.
(b) Nugiel, D.; Vidwans, A.; Etzkorn, A.; Rossi, K.; Benfield, P.; Burton, C.; Cox, S.; Czerniak, M.; Doleniak, D.; Seitz, S. J. Med. Chem. 2002, 45, 5224.
[9] For preparation of 2-arylidene-1,3-indanediones, please see: (a) Inayama, S.; Mamoto, K.; Shibata, T.; Hirose, T. J. Med. Chem. 1976, 19, 433.
(b) Wu, D. Y.; Ren, Z. J.; Cao, W. G.; Tong, W. Q. Synth. Commun. 2005, 35, 3157.
(c) Sarvesh, P. K.; Nizamuddin, K. Arch. Pharm. Chem. Life Sci. 2008, 341, 418.
[10] For the asymmetric epoxidation, see: (a) Russo, A.; Lattanzi, A. Org. Biomol. Chem. 2010, 8, 2633. For the asymmetric cyclopropanation, see:
(b) Russo, A.; Meninno, S.; Tedesco, C.; Lattanzi, A. Eur. J. Org. Chem. 2011, 5096.
[11] Hua, F.-L.; Wei, Y.; Shi, M. Tetrahedron 2012, 68, 7911.
[12] (a) Ramachary, D. B.; Anebouselvy, K.; Chowdari, N. S.; Barbas Ⅲ, C. F. J. Org. Chem. 2004, 69, 5838. For an asymmetric [2+2+2] annulation, see:
(b) Kuan, H.-H.; Chien, C.-H.; Chen, K. Org. Lett. 2013, 15, 2880. For a non-asymmetric [4+2] cycloaddition, see:
(c) Li, E.-Q.; Huang, Y.; Liang, L.; Xie, P.-Z. Org. Lett. 2013, 15, 3138.
[13] (a) Lu, H.-H.; Liu, H.; Wu, W.; Wang, X.-F.; Lu, L.-Q.; Xiao, W.-J. Chem. Eur. J. 2009, 15, 2742.
(b) Wang, X.-F.; Hua, Q.-L.; Cheng, Y.; An, X.-L.; Yang, Q.-Q.; Chen, J.-R.; Xiao, W.-J. Angew. Chem. Int. Ed. 2010, 49, 8379.
(c) Wang, X.-F.; Cao, Y.-J.; Cheng, H.-G.; Chen, J.-R.; Xiao, W.-J. Org. Lett. 2010, 12, 1140.
(d) Zhu, X.-Y.; An, X.-L.; Li, C.-F.; Zhang, F.-G.; Hua, Q.-L.; Chen, J.-R.; Xiao, W.-J. ChemCatChem 2011, 3, 679.
(e) Cao, Y.-J.; Cheng, H.-G.; Lu, L.-Q.; Zhang, J.-J.; Cheng, Y.; Chen, J.-R.; Xiao, W.-J. Adv. Synth. Catal. 2011, 353, 617.
(f) Tan, F.; Xiao, C.; Cheng, H.-G.; Wu, W.; Ding, K.-R.; Xiao, W.-J. Chem. Asian J. 2012, 7, 493.
(g) Tan, F.; Cheng, H.-G.; Feng, B.; Zou, Y.-Q.; Duan, S.-W.; Chen, J.-R.; Xiao, W.-J. Eur. J. Org. Chem. 2013, 2071.
(h) Cheng, H.-G.; Lu, L.-Q.; Wang, T.; Yang, Q.-Q.; Liu, X.-P.; Li, Y.; Deng, Q.-H.; Chen, J.-R.; Xiao, W.-J. Angew. Chem. Int. Ed. 2013, 52, 3250.
(i) Tan, F.; Lu, L.-Q.; Yang, Q.-Q.; Guo, W.; Bian, Q.; Chen, J.-R.; Xiao, W.-J. Chem. Eur. J. 2014, 20, 3415.
[14] Cheng, H.-G.; Lu, L.-Q.; Wang, T.; Chen, J.-R.; Xiao, W.-J. Chem. Commun. 2012, 48, 5596.
[15]For selected reviews on the applications of chiral bis(oxazoline) ligands in asymmetric catalysis, see: (a) Johnson, J. S.; Evans, D. A. Acc. Chem. Res. 2000, 33, 325.
(b) Desimoni, G.; Faita, G.; Jørgensen, K. A. Chem. Rev. 2006, 106, 3561.
(c) Hargaden, G. C.; Guiry, P. J. Chem. Rev. 2009, 109, 2505.
(d) Desimoni, G.; Faita, G.; Jørgensen, K. A. Chem. Rev. 2011, 111, PR284.

Sc(OTf)₃/Bis(oxazoline)复合物催化的2-芳基-1,3-茚二酮与2-乙烯基吲哚的不对称Diels-Alder反应：高效构建四氢咔唑螺茚酮衍生物

Asymmetric Diels-Alder Reaction of 2-Arylidene-1,3-indanediones with 2-Vinylindoles Catalyzed by a Sc(OTf)₃/Bis(oxazoline) Complex：Enantioselective Synthesis of Tetrahydrocarbazole Spiro Indanedione Derivatives

PDF

补充材料

可视化

摘要/Abstract

引用此文

分享此文

参考文献

相关文章 15

编辑推荐

相关统计

本文评价

[1]	邓卓基, 欧阳溢凡, 敖运林, 蔡倩. 铜催化不对称去对称化分子内烯基C—N偶联反应[J]. 化学学报, 2021, 79(5): 649-652.
[2]	尚阳, 肖检, 王雅雯, 彭羽. 不对称构筑二芳基次甲基立体中心的研究进展[J]. 化学学报, 2021, 79(11): 1303-1319.
[3]	李翼, 徐明华. 不对称Petasis反应在手性胺类化合物合成中的应用[J]. 化学学报, 2021, 79(11): 1345-1359.
[4]	程磊, 周其林. 镍催化构筑C(sp³)—C(sp³)键反应研究进展[J]. 化学学报, 2020, 78(10): 1017-1029.
[5]	周远春, 周志, 杜玮, 陈应春. HOMO活化的2-吡喃酮与2,5-二烯酮反电子需求的不对称Diels-Alder反应[J]. 化学学报, 2018, 76(5): 382-386.
[6]	母伟花, 马瑶, 方德彩, 王蓉, 张海娜. 1-碘-2-锂-邻碳硼烷与环戊二烯衍生物的类Diels-Alder反应的理论研究[J]. 化学学报, 2018, 76(1): 55-61.
[7]	于月娜, 徐明华. 手性磷-烯配体在不对称催化领域的研究进展[J]. 化学学报, 2017, 75(7): 655-670.
[8]	何展荣, 黄毅勇, Verpoort Francis. 基于三氟甲基砌块的催化不对称傅-克反应研究进展[J]. 化学学报, 2013, 71(05): 700-712.
[9]	吕健, 钟兴仁, 程津培, 罗三中. 不对称双酸催化3,4-二氢-2H-吡喃的反电子Hetero-Diels-Alder反应[J]. 化学学报, 2012, 70(14): 1518-1522.
[10]	孙允凯, 张劲, 曹靖, 欧阳昆冰, 阳年发. 含芴基的旋光末端环氧和环硫化合物的合成[J]. 化学学报, 2010, 68(20): 2086-2090.
[11]	王岩, 曾小兰, 方德彩. 硅苯和锗苯与2,3-二甲基丁二烯杂Diels-Alder反应的理论研究[J]. 化学学报, 2010, 68(10): 941-947.
[12]	林丽榕, 胡望霞, 马杰, 章慧, 黄荣彬, 郑兰荪. 缩氨基(硫)脲席夫碱化合物的自发对称性破缺研究[J]. 化学学报, 2010, 68(07): 703-706.
[13]	王岩, 方德彩, 刘若庄. 吡啶二硫代酯与丁二烯杂Diels-Alder反应的理论研究[J]. 化学学报, 2007, 65(18): 1987-1994.
[14]	王建平,程习星,陈庆华. 某些官能化手性氮杂环丙烷衍生物的合成及其结构[J]. 化学学报, 2006, 64(7): 686-690.
[15]	陆占国. 经由o-Quinonemethide的trans-Hexahydrocannabinol的简便合成[J]. 化学学报, 2006, 64(17): 1843-1846.